NEW YORK, March 31, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been
filed on behalf of shareholders of SCYNEXIS, Inc. (NASDAQ:SCYX) who purchased shares (1) pursuant and/or traceable to the
Registration Statement and Prospectus issued in connection with the Company’s Initial Public Offering on or about May 2, 2014
and/or (2) between May 2, 2014 and March 2, 2017. You are hereby notified that a securities class action lawsuit has been commenced
in the USDC for the District of New Jersey.
In particular complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or
failed to disclose that: (i) SCYNEXIS’s lead product SCY-078 posed substantial undisclosed health and safety risks; (ii)
consequently, the Company had overstated the drug’s approval prospects and/or commercial viability; and (iii) as a result of the
foregoing, SCYNEXIS’s public statements were materially false and misleading at all relevant times.
On March 2, 2017, SCYNEXIS announced that the U.S. Food and Drug Administration “informed the Company to hold the initiation of
any new clinical studies with the intravenous (IV) formulation of SCY-078 until the FDA completes a review of all available
pre-clinical and clinical data” of the formulation. The hold stems from “three mild-to-moderate thrombotic events in healthy
volunteers” receiving the formulation.
Shareholders have until May 8, 2017 to petition the court for lead plaintiff status. Your ability to share in
any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph
Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/scynexis-inc.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein
represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
